Literature DB >> 28572392

A modular and enantioselective synthesis of the pleuromutilin antibiotics.

Stephen K Murphy1, Mingshuo Zeng1, Seth B Herzon2,3.   

Abstract

The tricyclic diterpene fungal metabolite (+)-pleuromutilin has served as a starting point for antibiotic development. Semisynthetic modification of its glycolic acid subunit at C14 provided the first analogs fit for human use, and derivatization at C12 led to 12-epi-pleuromutilins with extended-spectrum antibacterial activity, including activity against Gram-negative pathogens. Given the inherent limitations of semisynthesis, however, accessing derivatives of (+)-pleuromutilin with full control over their structure presents an opportunity to develop derivatives with improved antibacterial activities. Here we disclose a modular synthesis of pleuromutilins by the convergent union of an enimide with a bifunctional iodoether. We illustrate our approach through synthesis of (+)-12-epi-mutilin, (+)-11,12-di-epi-mutilin, (+)-12-epi-pleuromutilin, (+)-11,12-di-epi-pleuromutilin, and (+)-pleuromutilin itself in 17 to 20 steps.
Copyright © 2017, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28572392      PMCID: PMC7001679          DOI: 10.1126/science.aan0003

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  23 in total

1.  A stereoselective, Sm(II)-mediated approach to decorated cis-hydrindanes: synthetic studies on faurinone and pleuromutilin.

Authors:  Thomas J K Findley; David Sucunza; Laura C Miller; Matthew D Helm; Madeleine Helliwell; David T Davies; David J Procter
Journal:  Org Biomol Chem       Date:  2011-02-15       Impact factor: 3.876

Review 2.  Molecular mechanisms of antibiotic resistance.

Authors:  Jessica M A Blair; Mark A Webber; Alison J Baylay; David O Ogbolu; Laura J V Piddock
Journal:  Nat Rev Microbiol       Date:  2014-12-01       Impact factor: 60.633

3.  Nickel-Catalyzed Regiodivergent Approach to Macrolide Motifs.

Authors:  Abdur-Rafay Shareef; David H Sherman; John Montgomery
Journal:  Chem Sci       Date:  2011-12-06       Impact factor: 9.825

4.  Some studies in the biosynthesis of terpenes and related compounds.

Authors:  D Arigoni
Journal:  Pure Appl Chem       Date:  1968       Impact factor: 2.453

5.  Exo-selective reductive macrocyclization of ynals.

Authors:  Hengbin Wang; Solymar Negretti; Allison R Knauff; John Montgomery
Journal:  Org Lett       Date:  2015-03-06       Impact factor: 6.005

6.  Mechanistic Basis for Regioselection and Regiodivergence in Nickel-Catalyzed Reductive Couplings.

Authors:  Evan P Jackson; Hasnain A Malik; Grant J Sormunen; Ryan D Baxter; Peng Liu; Hengbin Wang; Abdur-Rafay Shareef; John Montgomery
Journal:  Acc Chem Res       Date:  2015-05-12       Impact factor: 22.384

7.  Instantaneous SmI2/H2O/amine-mediated reductions in THF.

Authors:  Anders Dahlén; Göran Hilmersson
Journal:  Chemistry       Date:  2003-03-03       Impact factor: 5.236

Review 8.  The evolving role of chemical synthesis in antibacterial drug discovery.

Authors:  Peter M Wright; Ian B Seiple; Andrew G Myers
Journal:  Angew Chem Int Ed Engl       Date:  2014-07-02       Impact factor: 15.336

9.  A concise synthesis of the tricyclic skeleton of pleuromutilin and a new approach to cycloheptenes.

Authors:  Eric Bacqué; François Pautrat; Samir Z Zard
Journal:  Org Lett       Date:  2003-02-06       Impact factor: 6.005

10.  Regioselectivity and enantioselectivity in nickel-catalysed reductive coupling reactions of alkynes.

Authors:  Ryan M Moslin; Karen Miller-Moslin; Timothy F Jamison
Journal:  Chem Commun (Camb)       Date:  2007-07-03       Impact factor: 6.222

View more
  14 in total

Review 1.  Natural Products in the "Marketplace": Interfacing Synthesis and Biology.

Authors:  Benjamin J Huffman; Ryan A Shenvi
Journal:  J Am Chem Soc       Date:  2019-02-13       Impact factor: 15.419

2.  Re-engineering natural products to engage new biological targets.

Authors:  Stephen E Motika; Paul J Hergenrother
Journal:  Nat Prod Rep       Date:  2020-11-18       Impact factor: 13.423

3.  Fixing the Unfixable: The Art of Optimizing Natural Products for Human Medicine.

Authors:  Audrey E Yñigez-Gutierrez; Brian O Bachmann
Journal:  J Med Chem       Date:  2019-04-26       Impact factor: 7.446

4.  Total Synthesis of (+)-Pleuromutilin.

Authors:  Elliot P Farney; Sean S Feng; Felix Schäfers; Sarah E Reisman
Journal:  J Am Chem Soc       Date:  2018-01-17       Impact factor: 15.419

5.  Development of a Modular Synthetic Route to (+)-Pleuromutilin, (+)-12-epi-Mutilins, and Related Structures.

Authors:  Mingshuo Zeng; Stephen K Murphy; Seth B Herzon
Journal:  J Am Chem Soc       Date:  2017-11-02       Impact factor: 15.419

6.  Directed evolution of the rRNA methylating enzyme Cfr reveals molecular basis of antibiotic resistance.

Authors:  Kaitlyn Tsai; Vanja Stojković; Lianet Noda-Garcia; Iris D Young; Alexander G Myasnikov; Jordan Kleinman; Ali Palla; Stephen N Floor; Adam Frost; James S Fraser; Dan S Tawfik; Danica Galonić Fujimori
Journal:  Elife       Date:  2022-01-11       Impact factor: 8.140

7.  Total synthesis of structurally diverse pleuromutilin antibiotics.

Authors:  Olivia Goethe; Mikaela DiBello; Seth B Herzon
Journal:  Nat Chem       Date:  2022-09-26       Impact factor: 24.274

8.  Stable, Well-Defined Nickel(0) Catalysts for Catalytic C-C and C-N Bond Formation.

Authors:  Alex J Nett; Santiago Cañellas; Yuki Higuchi; Michael T Robo; Jeanne M Kochkodan; M Taylor Haynes; Jeff W Kampf; John Montgomery
Journal:  ACS Catal       Date:  2018-06-11       Impact factor: 13.084

9.  Scalable Synthesis of a Key Intermediate for the Production of Pleuromutilin-Based Antibiotics.

Authors:  Stephen K Murphy; Mingshuo Zeng; Seth B Herzon
Journal:  Org Lett       Date:  2017-08-31       Impact factor: 6.005

Review 10.  Total synthesis of complex terpenoids employing radical cascade processes.

Authors:  Kevin Hung; Xirui Hu; Thomas J Maimone
Journal:  Nat Prod Rep       Date:  2018-02-21       Impact factor: 13.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.